Ketamine-assisted psychotherapy for the treatment of persistent depression in abstinent opioid users

Date Added
December 7th, 2021
PRO Number
Pro00115696
Researcher
Eric Dobson

List of Studies

Keywords
Depression, Mental Health, Psychiatry, Substance Use
Summary

The purpose of the study is to examine whether an investigational medication called ketamine along with psychotherapy is an effective treatment for depression in participants with a history of opioid addiction who have not abused opioids in at least 3 months. Participants will receive ketamine through intramuscular injection along with psychotherapy weekly for 8 weeks. Participation for eligible subjects who decide to enroll (including post-medication follow-up visits) will last about 16 weeks or 4 months.

Institution
MUSC
Recruitment Contact
Eric Dobson
843-729-1445
dobsoner@musc.edu



-- OR --